Henagliflozin is a pharmaceutical drug for the treatment of type 2 diabetes.

[1] In China, it is approved for adult patients with type 2 diabetes to improve the glycemic control.

[2][3] Henagliflozin, like other drugs of the gliflozin class, inhibits the transporter protein sodium/glucose cotransporter 2 (SGLT2) which leads to a reduction in blood glucose levels.

[4]